Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-25 @ 2:19 AM
NCT ID:
NCT00747734
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Incurable, locally advanced, or metastatic solid malignancy that has progressed on, or failed to respond to, at least one prior regimen
* Evaluable or measurable disease per RECIST (in certain circumstances, prostate or ovarian cancer patients with non-measurable disease)
Exclusion Criteria:
* Inadequate hematologic or organ function
* Anti-cancer therapy within 4 weeks prior to initiation of study treatment
* Recent history of or current clinically significant gastrointestinal, cardiovascular or pulmonary disorders
* Any condition requiring full-dose anticoagulants, such as warfarin, heparin, or thrombolytics, or a filter of the inferior vena cava
* Active infection or autoimmune disease
* Known human immunodeficiency virus (HIV) infection
* Pregnancy or breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00747734
Study Brief:
Protocol Section:
NCT00747734